Sfoglia per AUTORE
SAGLIO G
Collezione AO Ordine Mauriziano

  

Items : 24

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study. in European journal of haematology / Eur J Haematol. 2025 Jan;114(1):37-44. doi: 10.1111/ejh.14299. Epub 2024 Sep 12.
2025
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Tiribelli M; Iurlo A; Breccia M; Saglio G; Specchia G; Malato A; Abruzzese E; Bocchia M; Fava C; Vincelli DI; Galimberti S; Luzi D; Murgano P; Rapezzi D; Sancetta R; Crugnola M; Stagno F; Maggi A; Leporace AP; Scortechini AR; Di Veroli A; Sportoletti P; Crisà E; Binotto G; Attolico I; Mullai R; Elena C; Lunghi F; Loglisci G; et alii...

2024
AO Ordine Mauriziano

Frolli A; Varvello S; Balbo Mussetto A; Gottardi D; Bullo M; Marini S; Saglio G; Cirillo S; Cilloni D; Parvis GE;

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety. in Journal of medicinal chemistry / J Med Chem. 2022 Oct 13;65(19):12701-12724. doi: 10.1021/acs.jmedchem.2c00496. Epub 2022 Sep 26.
2022
AO Ordine Mauriziano

Sainas S; Giorgis M; Circosta P; Poli G; Alberti M; Passoni A; Gaidano V; Pippione AC; Vitale N; Bonanni D; Rolando B; Cignetti A; Ramondetti C; Lanno A; Ferraris DM; Canepa B; Buccinnà B; Piccinini M; Rizzi M; Saglio G; Al-Karadaghi S; Boschi D; Miggiano R; Tuccinardi T; Lolli ML;

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Soverini S; Albano F; Simula MP; Sorà F; Porretto F; Cavazzini F; Cedrone M; Trabacchi E; Bocchia M; Martino B; Tiribelli M; Rege-Cambrin G; Stagno F; D'Adda M; Salvucci M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia. in Cell death & disease / Cell Death Dis. 2022 Jun 30;13(6):576. doi: 10.1038/s41419-022-05028-9.
2022
AOU Alessandria
AO Ordine Mauriziano

Oliviero S; Taverna D; Castagnetti F; Caocci G; Mulas O; Breccia M; Abruzzese E; Iurlo A; Sora F; Geuna M; Gai M; Passoni A; Fava C; Boschi D; Giorgis M; Gaidano V; Sainas S; Molineris I; Cignetti A; Orso F; Vitale N; Houshmand M; Pane F; Lolli ML; Circosta P; Saglio G;

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety. in Journal of medicinal chemistry / J Med Chem. 2021 May 13;64(9):5404-5428. doi: 10.1021/acs.jmedchem.0c01549. Epub 2021 Apr 12.
2021
AOU Alessandria
AO Ordine Mauriziano

Lolli ML; Saglio G; Boschi D; Al-Karadaghi S; Giraudo E; Cignetti A; Piccinini M; Houshmand M; Buccinnà B; Mishina M; Ramondetti C; Bona A; Rolando B; Canepa B; Cojocaru CF; Qiu Y; Passoni A; Bagnati R; Pippione AC; Bonanni D; Gaidano V; Circosta P; Giorgis M; Sainas S;

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. in Cancers / Cancers (Basel). 2021 Mar 15;13(6):1311. doi: 10.3390/cancers13061311.
2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino

Saglio G; Circosta P; Aime S; Russo S; Iurlo A; Stagno F; Pregno P; Martino B; Bonifacio M; Binotto G; Bocchia M; Specchia G; Luciano L; Annunziata M; Galimberti S; Pungolino E; Nikougoftar Zarif M; Fava C; Spinelli M; Cignetti A; Gaidano V; Stefania R; Garello F; Houshmand M;

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Specchia G; Pizzuti M; Ciccone G; Saglio G; Caocci G; La Barba G; Stagno F; Martino B; Luciano L; Scortechini AR; Gozzini A; Tiribelli M; Bonifacio M; Castagnetti F; Breccia M; Pregno P;

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia. in Cancers / Cancers (Basel). 2021 Feb 28;13(5):1003. doi: 10.3390/cancers13051003.
2021
AOU Alessandria
AO Ordine Mauriziano

Cignetti A; Cilloni D; Lolli ML; Boschi D; Giorgis M; Pippione AC; Sainas S; Rapelli S; Tenace V; Morotti A; Carrà G; Vitale N; Houshmand M; Gaidano V; Saglio G; Circosta P;

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells. in Journal of clinical medicine / J Clin Med. 2021 Dec 11;10(24):5805. doi: 10.3390/jcm10245805.
2021
AOU Alessandria
AO Ordine Mauriziano

Circosta P; Cilloni D; Saglio G; Fava C; Gaidano V; Cignetti A; Ali MS; Anjam Najmedini A; Kazemi A; Houshmand M;

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021018. doi: 10.4084/MJHID.2021.018. eCollection 2
2021
AO Ordine Mauriziano

Saglio G; Radice T; Passerini R; Fiori S; Gottardi D; Pagan E; Bagnardi V; Sammassimo S; Cignetti A; Ceparano G; Ramadan S; Tarella C;

2020
AOU Alessandria
AO Ordine Mauriziano

De Rosa G; Saglio G; Prato G; Cignetti A; Varvello S; Santoro N; Tenace V; Gaidano V; Geuna M;

Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia. in Journal of cellular and molecular medicine / J Cell Mol Med. 2020 Jan;24(2):1650-1657. doi: 10.1111/jcmm.14857. Epub 2019 Dec 10.
2020
AO Ordine Mauriziano

Guerrasio A; Gaidano V; Parvis G; Brancaccio M; Circosta P; Cartellà A; Maffeo B; Lingua MF; Nicoli P; Carrà G; Saglio G; Taulli R; Morotti A;

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pileri SA; Percesepe A; Laginestra MA; Mignone F; Vigneri P; Pane F; Errichiello S; Saglio G; Serra A; Stella S; Bocchia M; Calistri E; Annunziata M; Musolino C; Attolico I; Girasoli M; Coluzzi S; Capodanno I; Salvucci M; Sancetta R; Abruzzese E; Binotto G; D'Adda M; di Bona E; di Raimondo F; Stagno F; Russo Rossi AV; Albano F; Gugliotta G; et alii...

Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia? in Haematologica / Haematologica. 2019 May;104(5):862-864. doi: 10.3324/haematol.2018.214445.
2019
AO Ordine Mauriziano

Saglio G; Fava C; Gale RP;

Chronic myeloid leukemia stem cells. in Leukemia / Leukemia. 2019 Jul;33(7):1543-1556. doi: 10.1038/s41375-019-0490-0. Epub 2019 May 24.
2019
AO Ordine Mauriziano

Houshmand M; Simonetti G; Circosta P; Gaidano V; Cignetti A; Martinelli G; Saglio G; Gale RP;

2019
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Santini V; Levis A; Musto P; Tassara R; Finelli C; Saglio G; Bonferroni M; Allione B; Balleari E; Poloni A; Cametti G; Ferrero D; Sanna A; Ceccarelli M; Salvi F; Danise P; Masiera E; Castiglione A; Gioia D; Messa E; Messa E; Gioia D; Masiera E; Castiglione A; Ceccarelli M; Salvi F; Danise P; Sanna A; Allione B; et alii...

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper. in Journal of hematology & oncology / J Hematol Oncol. 2019 Dec 5;12(1):131. doi: 10.1186/s13045-019-0815-5.
2019
AO Ordine Mauriziano
AOU Città della Salute di Torino

Tiribelli M; Vigneri P; Stagno F; Saglio G; Rosti G; Pregno P; Luciano L; Gozzini A; Iurlo A; Galimberti S; Bonifacio M; Abruzzese E; Bocchia M; Soverini S; Barosi G; Breccia M;

Present results and future perspectives in optimizing chronic myeloid leukemia therapy. in Haematologica / Haematologica. 2018 Jun;103(6):928-930. doi: 10.3324/haematol.2017.182022.
2018
AO Ordine Mauriziano

Carella AM; Saglio G; Mahon XF; Mauro MJ;

Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. in Journal of medicinal chemistry / J Med Chem. 2018 Jul 26;61(14):6034-6055. doi: 10.1021/acs.jmedchem.8b00373. Epub 2018 Jul 9.
2018
AO Ordine Mauriziano

Sainas S; Pippione AC; Lupino E; Giorgis M; Circosta P; Gaidano V; Goyal P; Bonanni D; Rolando B; Cignetti A; Ducime A; Andersson M; Järvå M; Friemann R; Piccinini M; Ramondetti C; Buccinnà B; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML;

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Baccarani M; Specchia G; Cortelezzi A; Saglio G; Rosti G; Pane F; Bocchia M; Sica S; Breccia M; Luciano L; Martino B; Rege-Cambrin G; Stagno F; Castagnetti F; Gugliotta G; Tiribelli M; Gozzini A; Pungolino E; Bucelli C; Binotto G; Cattaneo D; Fava C; Orlandi EM; Sorà F; Ferrero D; Pregno P; Latagliata R; Annunziata M; Bonifacio M; et alii...

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia. in Oncotarget / Oncotarget. 2017 Sep 30;8(50):88021-88033. doi: 10.18632/oncotarget.21406. eCollection 2017 Oct 20.
2017
AO Ordine Mauriziano

Galimberti S; Bucelli C; Arrigoni E; Baratè C; Grassi S; Ricci F; Guerrini F; Ciabatti E; Fava C; D'Avolio A; Fontanelli G; Cambrin GR; Isidori A; Loscocco F; Caocci G; Greco M; Bocchia M; Aprile L; Gozzini A; Scappini B; Cattaneo D; Scortechini AR; La Nasa G; Bosi A; Leoni P; Danesi R; Saglio G; Visani G; Cortelezzi A; et alii...

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib. in American journal of hematology / Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.
2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Giovanni M; Cavo M; Bochicchio MT; Soverini S; Bocchia M; Gherlinzoni F; Fava C; Bonifacio M; Sica S; Tiribelli M; Usala E; Annunziata M; Pregno P; Orlandi E; Martino B; Cavazzini F; Rossi G; Rupoli S; Vigneri P; Abruzzese E; Albano F; Iurlo A; Levato L; Breccia M; Gugliotta G; Castagnetti F; Saglio G; Pane F; Baccarani M; et alii...

The biology of CML supports second-generation TKIs as frontline treatment. in Clinical advances in hematology & oncology : H&O / Clin Adv Hematol Oncol. 2017 Apr;15(4):302-307.
2017
AO Ordine Mauriziano

Fava C; Saglio G;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte